Salivary gland cancer organoids are valid for preclinical genotype-oriented medical precision trials. Tomohiko Ishikawa et al.
Published: 27 April 2023| Version 1 | DOI: 10.17632/s2njncjd5s.1
Contributors:
, Description
・Mutational signature from WES analysis. ・Cell viability assay using alamarblue. ・Imaging analysis using ImageJ. ・Western blotting unprocessed images.
Files
Categories
Data Access